Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Number of holders
-
459
-
Total 13F shares, excl. options
-
23,366,967
-
Shares change
-
-2,247,463
-
Total reported value, excl. options
-
$1,745,726,599
-
Value change
-
-$180,784,054
-
Put/Call ratio
-
185%
-
Number of buys
-
208
-
Number of sells
-
-222
-
Price
-
$74.72
Significant Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q3 2021
572 filings reported holding ARKG - ARK ETF TR - GENOMIC REV ETF as of Q3 2021.
ARK ETF TR - GENOMIC REV ETF (ARKG) has 459 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23,366,967 shares
.
Largest 10 shareholders include MORGAN STANLEY (3,740,533 shares), BANK OF AMERICA CORP /DE/ (2,053,793 shares), LPL Financial LLC (1,235,499 shares), UBS Group AG (1,184,279 shares), WELLS FARGO & COMPANY/MN (809,285 shares), Eversept Partners, LP (689,501 shares), COMMONWEALTH EQUITY SERVICES, LLC (671,589 shares), ADVISOR GROUP HOLDINGS, INC. (519,924 shares), CITIGROUP INC (425,937 shares), and ROYAL BANK OF CANADA (418,752 shares).
This table shows the top 459 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.